Wednesday, March 29, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

NIAID Seeks Non-Human Primate Lab Testing Services

by Stephanie Lizotte
January 5, 2012
Non-Human Primate (NHP) Testing Services

The National Institute of Allergy and Infectious Disease (NIAID) has issued a solicitation for non-human primate laboratory testing services. The samples to be tested are in support of research on Simian Immunodeficiency Virus (SIV), which is very similar to Human Immunodeficiency Virus in humans.

Companies must demonstrate expertise in sample handling and preparation of a wide variety of clinical submissions such as Complete Blood Counts, Blood Chemistry Analysis, Urinalysis, Bone Marrow Aspirates and Cerebral Spinal Fluid Samples.

The data obtained is used to determine the health and well being of non-human primates assigned to Animal Study Proposals. In turn, this data assists in enabling both Investigative Research staff in conjunction with Research and Clinical Veterinary staff to determine the animals’ current status of Simian Immunodeficiency Virus (SIV), which is very similar to Human Immunodeficiency Virus in humans.

The contract to be awarded is for 1 base year and 4 option years. Estimated volume is 150-200 specimens per month. The response deadline for organizations capable of fulfilling this service is January 17, 2012. Please see the official announcement here for complete information.

Tags: HIVNIAIDNIHNon-Human PrimateRequest for Quotes

Related Posts

Medical Countermeasures

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
Load More

Latest News

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC